CONTACT INFORMATION

Office : (852) 3505-3308

Email : delonhsueh@cuhk.edu.hk

ACADEMIC ENGAGEMENT

Postgraduate teaching:
MPhil/PhD in Orthopaedics & Traumatology

ORCID: 0009-0004-0942-2143

B.S (NCKU, Taiwan), Ph.D. (NTU, Taiwan)

Research Assistant Professor
研究助理教授

BIOGRAPHY

Dr. Hsueh is a Research Assistant Professor in the Department of Orthopaedics & Traumatology, the Chinese University of Hong Kong (CUHK). He received his Ph.D. in biomaterials from the Department of Biomedical Engineering, College of Medicine and Engineering, National Taiwan University (NTU) in 2014. He holds a bachelor’s degree in Chemical Engineering, National Cheng Kung University (NCKU), Taiwan. He was a visiting scholar at the Institute for Frontier Medical Sciences, Kyoto University, Japan (2012) and Department of Plastic Surgery, Charles University, Prague, Czech Republic (2013), where he was engaged in medical research in the field of tissue engineering (evaluation of human neural progenitor cells derived from induced pluripotent stem cells (iPS cells) by utilizing extracellular matrix protein-screening microarrays) as well as in pre-clinical and clinical investigations (soft-tissue reconstruction), respectively.

Dr. Hsueh specializes in the regulatory science and orthopedic research. He also works closely with the Centre of Neuromusculoskeletal Restorative Medicine (CNRM) of InnoHK cluster research centre as a strategic consultant to convert translational medicine. He is also committed to the development of biomaterials in the field of oncology (hyperthermia), peripheral nerve and soft tissue regeneration.

Dr. Hsueh has more than 10 years of R&D experience in biomedical engineering and many years of regulation & market oversight experience at the Taiwan Food and Drug Administration (TFDA). Prior to joining CUHK, he served at TFDA as a Technical Specialist (Grade 9, 2019), starting from a postdoctoral fellow (2015) in policy recommendations (selected agendas include: Regulatory science grant proposals, Talent development scheme, and Medical device re-evaluation mechanism). His areas of expertise cover the entire life cycle of medical devices, from conceptualization to validation (non-clinical and clinical evaluation), from manufacturing compliance (ISO 13485, QMS) to product approval (clearance); he has also devoted to post-market surveillance (CAPA > 300 cases), and on the design and implementation of audit mechanism (>10+ protocols, from Class I to Class III devices). As a regulatory scientist, he is committed to the development of translational medicine and will continue to contribute to regulatory science and research.

• Regulatory Science
• Translational medicine Research
• Tissue Regeneration
• Cell Therapy

• Regulatory Science research for Orthopaedics
• Translational research on Biodegradable Materials for Orthopaedics Applications
• Advanced therapy products (ATPs)
• Class III medical devices and Biomaterials
• Musculoskeletal tissue engineering